Open access · CC-BY
via OpenAlex
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
Dawn Béraud, Hannah A. Hathaway, Jordan Trecki, Sergey Chasovskikh, Delinda A. Johnson, Jeffrey Allan Johnson, Howard J. Federoff, Mika Shimoji, Timothy R. Mhyre, Kathleen A. Maguire‐Zeiss
Journal of Neuroimmune Pharmacology · 2012 · ▲ 173 citations
Abstract
Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder typified by tremor, rigidity, akinesia and postural instability due in part to the loss of dopamine within the nigrostriatal system. The pathologic features of this disorder include the loss of substantia nigra dopamine neurons and attendant striatal terminals, the presence of large protein-rich neuronal inclusions containing fibrillar α-synuclein and increased numbers of activated microglia. Evidence suggests that both misfolded α-synuclein and oxidative stress play an important role in the pathogenesis of sporadic PD. Here we review evidence that α-synuclein activates glia inducing inflammation and that Nrf2-directed phase-II antioxidant enzymes play an important role in PD. We also provide new evidence that the expression of antioxidant enzymes regulated in part by Nrf2 is increased in a mouse model of α-synuclein overexpression. We show that misfolded α-synuclein directly activates microglia inducing the production and release of the proinflammatory cytokine, TNF-α, and increasing antioxidant enzyme expression. Importantly, we demonstrate that the precise structure of α-synuclein is important for induction of this proinflammatory pathway. This complex α-synuclein-directed glial response highlights the importance of protein misfolding, oxidative stress and inflammation in PD and represents a potential locus for the development of novel therapeutics focused on induction of the Nrf2-directed antioxidant pathway and inhibition of protein misfolding.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s11481-012-9401-0
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Béraud, D., Hathaway, H.A., Trecki, J., Chasovskikh, S., Johnson, D.A., Johnson, J.A., Federoff, H.J., Shimoji, M., Mhyre, T.R., & Maguire‐Zeiss, K.A. (2012). Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein. <em>Journal of Neuroimmune Pharmacology</em>. https://doi.org/10.1007/s11481-012-9401-0
Vancouver
Béraud D, Hathaway HA, Trecki J, Chasovskikh S, Johnson DA, Johnson JA, et al. Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein. Journal of Neuroimmune Pharmacology. 2012. doi:10.1007/s11481-012-9401-0.
BibTeX
@article{dawn2012Microg,
title = {Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein},
author = {Dawn Béraud and Hannah A. Hathaway and Jordan Trecki and Sergey Chasovskikh and Delinda A. Johnson and Jeffrey Allan Johnson and Howard J. Federoff and Mika Shimoji and Timothy R. Mhyre and Kathleen A. Maguire‐Zeiss},
journal = {Journal of Neuroimmune Pharmacology},
year = {2012},
doi = {10.1007/s11481-012-9401-0},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neuroscience 2016
Open access · CC-BY
microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease
International Journal of Molecular Sciences 2018
Open access · CC-BY
Ageing, Cellular Senescence and Neurodegenerative Disease
Current Neuropharmacology 2018
Open access · OA
Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
Parkinson s Disease 2016
Open access · CC-BY
Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
D-Scholarship@Pitt (University of Pittsburgh) 2005
Preprint · OA
Extracellular Superoxide Dismutase and Matrix Metalloproteinases in Pulmonary Fibrosis
Molecular Neurodegeneration 2019
Open access · CC-BY